Bioforce AG acquired the shares it did not already own in its UK distributor Bioforce UK Ltd.
Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in its UK distributor Bioforce UK Ltd.
The company had been founded as a joint venture (Bioforce AG participation 25%) to distribute A.Vogel products in the UK. Due to the retirement of the Managing Shareholders, Bioforce AG took over the shares it did not already own to make Bioforce UK Ltd. a wholly-owned subsidiary.
Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.
Bioforce UK Ltd. is the exclusive distributor of A. Vogel / Bioforce products in the UK.
The transaction close don 31. August 2019.
Chemicals
acquired the shares it did not already own in its UK distributor
Transaction details
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution, acquired the shares it did not already own in its UK distributor Bioforce UK Ltd.
This transaction was advised by:
Our latest transactions
Software & IT Services
have sold
to
a portfolio company of
Transaction details
Technology field services and support provider Vista Technology Support has been acquired by TRG
Consumer Goods & Retail
has obtained fundraising from
Transaction details
High-end bicycle producer The Rider Firm has obtained fundraising from Santander
Software & IT Services
has raised growth capital from
Transaction details
Digital Pills, an Italian Data & AI consulting company, has sold a minority stake to Equiter, raising funds for its future growth
